Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Quantitative Trait Loci | 24 | 2024 | 2131 | 2.320 |
Why?
|
Genome-Wide Association Study | 55 | 2024 | 12790 | 2.260 |
Why?
|
Genetic Predisposition to Disease | 41 | 2025 | 18063 | 1.420 |
Why?
|
Polymorphism, Single Nucleotide | 49 | 2024 | 16036 | 1.380 |
Why?
|
Germ Cells | 7 | 2024 | 644 | 1.140 |
Why?
|
Inheritance Patterns | 4 | 2016 | 344 | 1.140 |
Why?
|
Neoplasms | 23 | 2024 | 22350 | 0.990 |
Why?
|
Chromosome Mapping | 11 | 2020 | 4616 | 0.920 |
Why?
|
Chromatin | 8 | 2025 | 2980 | 0.900 |
Why?
|
Alleles | 14 | 2024 | 6893 | 0.890 |
Why?
|
Linkage Disequilibrium | 17 | 2022 | 1996 | 0.890 |
Why?
|
Allelic Imbalance | 2 | 2022 | 77 | 0.860 |
Why?
|
Multifactorial Inheritance | 15 | 2024 | 1422 | 0.850 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2023 | 102 | 0.800 |
Why?
|
Genetics, Population | 6 | 2024 | 943 | 0.770 |
Why?
|
Models, Genetic | 19 | 2021 | 3445 | 0.720 |
Why?
|
Prostatic Neoplasms | 10 | 2024 | 11097 | 0.640 |
Why?
|
Disease | 5 | 2018 | 675 | 0.630 |
Why?
|
Genetic Variation | 9 | 2024 | 6611 | 0.600 |
Why?
|
Haplotypes | 9 | 2024 | 2722 | 0.560 |
Why?
|
Germ-Line Mutation | 7 | 2025 | 1885 | 0.550 |
Why?
|
Epigenesis, Genetic | 4 | 2021 | 3828 | 0.530 |
Why?
|
Autoimmune Diseases | 3 | 2023 | 2255 | 0.470 |
Why?
|
Genetic Diseases, Inborn | 2 | 2020 | 606 | 0.460 |
Why?
|
Prostate | 2 | 2021 | 1761 | 0.450 |
Why?
|
Gene Expression | 5 | 2023 | 7587 | 0.440 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.440 |
Why?
|
Algorithms | 13 | 2023 | 14098 | 0.410 |
Why?
|
Phenotype | 20 | 2024 | 16718 | 0.410 |
Why?
|
Open Reading Frames | 2 | 2016 | 818 | 0.400 |
Why?
|
Interleukin-7 | 2 | 2022 | 146 | 0.400 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2024 | 5389 | 0.390 |
Why?
|
Lung Neoplasms | 8 | 2024 | 13491 | 0.370 |
Why?
|
Mutation | 14 | 2024 | 30211 | 0.370 |
Why?
|
Computer Simulation | 11 | 2021 | 6260 | 0.360 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4780 | 0.350 |
Why?
|
Schizophrenia | 7 | 2024 | 6977 | 0.350 |
Why?
|
Genetic Loci | 5 | 2018 | 2629 | 0.350 |
Why?
|
Genotype | 12 | 2024 | 13035 | 0.350 |
Why?
|
Humans | 110 | 2025 | 767040 | 0.320 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4903 | 0.310 |
Why?
|
Immunotherapy | 6 | 2024 | 4745 | 0.300 |
Why?
|
Gene Frequency | 7 | 2024 | 3621 | 0.300 |
Why?
|
Computer Security | 2 | 2020 | 261 | 0.300 |
Why?
|
Genealogy and Heraldry | 3 | 2021 | 29 | 0.290 |
Why?
|
Kidney Neoplasms | 3 | 2023 | 4282 | 0.290 |
Why?
|
Melanoma | 5 | 2023 | 5702 | 0.280 |
Why?
|
Alternative Splicing | 2 | 2024 | 1103 | 0.270 |
Why?
|
Gene Expression Regulation | 8 | 2024 | 11923 | 0.270 |
Why?
|
Family Relations | 1 | 2008 | 318 | 0.260 |
Why?
|
Genetic Association Studies | 5 | 2021 | 2744 | 0.240 |
Why?
|
Molecular Sequence Annotation | 4 | 2021 | 526 | 0.240 |
Why?
|
Gene Regulatory Networks | 3 | 2024 | 1752 | 0.240 |
Why?
|
Databases, Genetic | 3 | 2021 | 1758 | 0.240 |
Why?
|
Genomic Structural Variation | 1 | 2025 | 80 | 0.230 |
Why?
|
Jews | 3 | 2016 | 359 | 0.220 |
Why?
|
Prurigo | 1 | 2023 | 26 | 0.210 |
Why?
|
Evolution, Molecular | 1 | 2011 | 1893 | 0.210 |
Why?
|
Hominidae | 1 | 2023 | 68 | 0.210 |
Why?
|
Drug Eruptions | 2 | 2024 | 335 | 0.200 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4114 | 0.200 |
Why?
|
Erythema Multiforme | 1 | 2022 | 31 | 0.200 |
Why?
|
HLA-A3 Antigen | 1 | 2021 | 34 | 0.200 |
Why?
|
Genomics | 8 | 2023 | 5924 | 0.190 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2023 | 792 | 0.190 |
Why?
|
Quantitative Trait, Heritable | 4 | 2020 | 539 | 0.190 |
Why?
|
Sequence Analysis, RNA | 3 | 2024 | 2040 | 0.190 |
Why?
|
Dermatitis | 1 | 2023 | 203 | 0.190 |
Why?
|
Vitiligo | 1 | 2022 | 97 | 0.180 |
Why?
|
Genetic Techniques | 3 | 2021 | 427 | 0.180 |
Why?
|
Histone Code | 1 | 2021 | 160 | 0.180 |
Why?
|
Pemphigoid, Bullous | 1 | 2022 | 110 | 0.180 |
Why?
|
Calibration | 2 | 2020 | 817 | 0.170 |
Why?
|
Models, Theoretical | 4 | 2017 | 3561 | 0.170 |
Why?
|
Atlases as Topic | 2 | 2024 | 247 | 0.170 |
Why?
|
Male | 37 | 2025 | 364203 | 0.170 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2022 | 231 | 0.170 |
Why?
|
Eczema | 1 | 2022 | 244 | 0.170 |
Why?
|
Gene Knockout Techniques | 2 | 2020 | 804 | 0.160 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1761 | 0.160 |
Why?
|
Pedigree | 3 | 2012 | 4539 | 0.160 |
Why?
|
Obesity | 2 | 2024 | 13085 | 0.160 |
Why?
|
Gene Fusion | 1 | 2021 | 356 | 0.150 |
Why?
|
Acetylation | 2 | 2023 | 1055 | 0.150 |
Why?
|
Exanthema | 1 | 2023 | 502 | 0.150 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2019 | 146 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3667 | 0.150 |
Why?
|
Thyroid Diseases | 1 | 2021 | 385 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.150 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1366 | 0.150 |
Why?
|
DNA Methylation | 2 | 2024 | 4426 | 0.140 |
Why?
|
Genome, Human | 5 | 2023 | 4441 | 0.140 |
Why?
|
Crohn Disease | 3 | 2016 | 2295 | 0.140 |
Why?
|
Computational Biology | 4 | 2021 | 3567 | 0.140 |
Why?
|
Regression Analysis | 4 | 2020 | 6331 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2020 | 8628 | 0.140 |
Why?
|
Carcinoma, Renal Cell | 2 | 2023 | 3186 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2018 | 474 | 0.130 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2016 | 22 | 0.130 |
Why?
|
Tumor Burden | 1 | 2022 | 1903 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2025 | 1266 | 0.130 |
Why?
|
Epistasis, Genetic | 2 | 2015 | 353 | 0.130 |
Why?
|
Protein Phosphatase 2 | 1 | 2018 | 231 | 0.130 |
Why?
|
Epigenomics | 4 | 2024 | 959 | 0.130 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5859 | 0.120 |
Why?
|
Skin Diseases | 1 | 2023 | 1083 | 0.120 |
Why?
|
Transcription Factors | 5 | 2023 | 12158 | 0.120 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9532 | 0.120 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 17097 | 0.120 |
Why?
|
Autistic Disorder | 1 | 2024 | 1239 | 0.120 |
Why?
|
Frameshift Mutation | 1 | 2016 | 392 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1105 | 0.110 |
Why?
|
Gene Dosage | 1 | 2018 | 1211 | 0.110 |
Why?
|
Patient Admission | 1 | 2021 | 1364 | 0.110 |
Why?
|
Earthquakes | 1 | 2016 | 192 | 0.110 |
Why?
|
Brain | 5 | 2024 | 27163 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2024 | 3610 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2018 | 1074 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2017 | 877 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2047 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 892 | 0.100 |
Why?
|
Female | 32 | 2025 | 396660 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1089 | 0.100 |
Why?
|
Breast Neoplasms | 5 | 2022 | 21178 | 0.100 |
Why?
|
Biostatistics | 1 | 2014 | 162 | 0.100 |
Why?
|
Bone Neoplasms | 1 | 2025 | 2563 | 0.100 |
Why?
|
Risk Factors | 13 | 2025 | 74886 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1019 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2252 | 0.100 |
Why?
|
Multiple Sclerosis | 3 | 2015 | 3229 | 0.090 |
Why?
|
Cell Survival | 1 | 2021 | 5750 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1802 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2022 | 1481 | 0.090 |
Why?
|
Zebrafish | 2 | 2022 | 3036 | 0.090 |
Why?
|
Cohort Studies | 10 | 2024 | 41718 | 0.090 |
Why?
|
Retrospective Studies | 10 | 2024 | 81659 | 0.090 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2698 | 0.080 |
Why?
|
Population Groups | 1 | 2010 | 209 | 0.080 |
Why?
|
Sterols | 1 | 2009 | 63 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2024 | 4881 | 0.080 |
Why?
|
Computer Graphics | 1 | 2011 | 345 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 2 | 2015 | 3778 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3253 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12536 | 0.080 |
Why?
|
Histones | 2 | 2016 | 2597 | 0.080 |
Why?
|
Aged | 15 | 2024 | 171319 | 0.070 |
Why?
|
Homozygote | 1 | 2012 | 1774 | 0.070 |
Why?
|
Case-Control Studies | 7 | 2024 | 22254 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3440 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12069 | 0.070 |
Why?
|
Middle Aged | 16 | 2024 | 223233 | 0.070 |
Why?
|
Oncogenes | 2 | 2023 | 1232 | 0.070 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 203 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2015 | 6215 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2666 | 0.070 |
Why?
|
Binding Sites | 3 | 2020 | 6014 | 0.070 |
Why?
|
Consanguinity | 1 | 2008 | 460 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2016 | 2647 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10254 | 0.060 |
Why?
|
Family | 1 | 2016 | 3210 | 0.060 |
Why?
|
HLA Antigens | 1 | 2011 | 1334 | 0.060 |
Why?
|
Cognition | 1 | 2022 | 7059 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5794 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 6573 | 0.060 |
Why?
|
Steroids | 1 | 2009 | 937 | 0.060 |
Why?
|
Mental Disorders | 1 | 2024 | 6873 | 0.060 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2023 | 28 | 0.060 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2023 | 129 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3797 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8717 | 0.050 |
Why?
|
Natural Language Processing | 2 | 2021 | 1202 | 0.050 |
Why?
|
Smoking | 3 | 2024 | 9081 | 0.050 |
Why?
|
Smoke | 1 | 2024 | 243 | 0.050 |
Why?
|
Africa South of the Sahara | 1 | 2024 | 751 | 0.050 |
Why?
|
Animals | 5 | 2023 | 168965 | 0.050 |
Why?
|
Phylogeny | 1 | 2008 | 2840 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 454 | 0.050 |
Why?
|
Micronesia | 2 | 2010 | 44 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59548 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 14672 | 0.040 |
Why?
|
Incidence | 3 | 2024 | 21526 | 0.040 |
Why?
|
Adult | 10 | 2025 | 223317 | 0.040 |
Why?
|
Risk Assessment | 4 | 2024 | 24299 | 0.040 |
Why?
|
Parkinson Disease | 1 | 2014 | 2886 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 165 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2021 | 437 | 0.040 |
Why?
|
Latin America | 1 | 2020 | 416 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2024 | 1716 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 369 | 0.040 |
Why?
|
Penetrance | 1 | 2021 | 388 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 765 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2025 | 1776 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 677 | 0.040 |
Why?
|
Models, Statistical | 2 | 2014 | 5098 | 0.040 |
Why?
|
Privacy | 1 | 2020 | 233 | 0.040 |
Why?
|
Genetic Load | 1 | 2016 | 15 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 506 | 0.030 |
Why?
|
Vesicular Transport Proteins | 1 | 2020 | 377 | 0.030 |
Why?
|
Protein Binding | 2 | 2020 | 9327 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 434 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1253 | 0.030 |
Why?
|
Blood Cells | 1 | 2018 | 309 | 0.030 |
Why?
|
Genetic Fitness | 1 | 2017 | 120 | 0.030 |
Why?
|
Immune System Diseases | 1 | 2018 | 253 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 965 | 0.030 |
Why?
|
Twins | 1 | 2017 | 341 | 0.030 |
Why?
|
Child, Preschool | 3 | 2025 | 42606 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1626 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2024 | 1381 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3273 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2016 | 507 | 0.030 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 319 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2020 | 1160 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2015 | 266 | 0.030 |
Why?
|
Body Mass Index | 3 | 2018 | 13048 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 976 | 0.030 |
Why?
|
Child | 4 | 2025 | 80771 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2018 | 2275 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2020 | 1089 | 0.030 |
Why?
|
Body Size | 1 | 2016 | 462 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2017 | 640 | 0.030 |
Why?
|
Mexico | 1 | 2016 | 769 | 0.030 |
Why?
|
Probability | 1 | 2019 | 2476 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9410 | 0.030 |
Why?
|
Estrogens | 1 | 2020 | 1536 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2022 | 2428 | 0.030 |
Why?
|
Time Factors | 3 | 2021 | 40154 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1076 | 0.030 |
Why?
|
DNA Damage | 1 | 2022 | 2469 | 0.020 |
Why?
|
Organ Specificity | 1 | 2017 | 1966 | 0.020 |
Why?
|
Connecticut | 1 | 2012 | 365 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2538 | 0.020 |
Why?
|
Leukocytes | 1 | 2020 | 2034 | 0.020 |
Why?
|
Sample Size | 1 | 2015 | 845 | 0.020 |
Why?
|
Genetic Markers | 1 | 2018 | 2602 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2018 | 2350 | 0.020 |
Why?
|
HLA-DR1 Antigen | 1 | 2011 | 11 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3582 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3431 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4280 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2015 | 1524 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 998 | 0.020 |
Why?
|
Sex Factors | 1 | 2025 | 10622 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2457 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2011 | 146 | 0.020 |
Why?
|
HLA-DQ Antigens | 1 | 2011 | 190 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2050 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2011 | 223 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3591 | 0.020 |
Why?
|
Population Surveillance | 1 | 2020 | 2594 | 0.020 |
Why?
|
New York | 1 | 2012 | 879 | 0.020 |
Why?
|
Disasters | 1 | 2016 | 521 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3449 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4522 | 0.020 |
Why?
|
HLA-B Antigens | 1 | 2011 | 330 | 0.020 |
Why?
|
Phytosterols | 1 | 2009 | 55 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3249 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2979 | 0.020 |
Why?
|
Triglycerides | 1 | 2017 | 2444 | 0.020 |
Why?
|
Founder Effect | 1 | 2009 | 185 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4648 | 0.020 |
Why?
|
Mice | 1 | 2016 | 81912 | 0.020 |
Why?
|
Skin | 1 | 2022 | 4499 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4210 | 0.020 |
Why?
|
Software | 2 | 2014 | 4472 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29963 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14766 | 0.020 |
Why?
|
United States | 3 | 2022 | 72971 | 0.020 |
Why?
|
Intestines | 1 | 2016 | 1905 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15851 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 89046 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2024 | 6360 | 0.020 |
Why?
|
Nurses | 1 | 2016 | 2501 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2598 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9245 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23713 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15567 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20169 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9606 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2009 | 566 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7611 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5886 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13284 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5875 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8351 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8068 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2021 | 65295 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13646 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9612 | 0.010 |
Why?
|
Anxiety | 1 | 2017 | 4670 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 59980 | 0.010 |
Why?
|
Genome | 1 | 2009 | 1752 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2018 | 5130 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36485 | 0.010 |
Why?
|
Neurons | 1 | 2018 | 9517 | 0.010 |
Why?
|
Depression | 1 | 2017 | 8234 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8729 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26325 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23621 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 12250 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15645 | 0.000 |
Why?
|